Kamel Khalili
17Patents
2h-index
15Co-inventors
47Inventor score
Filing activity: Jan 13, 2002 → Sep 10, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7589075B2 | Use of an adenosine A3 receptor agonist for inhibition of viral replication | Human Necessities | 9 | Expired |
| US11491207B2 | Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapy | Emerging Cross-Sectional Technologies | 4 | Active |
| US9981020B2 | Methods and compositions for RNA-guided treatment of HIV infection | Chemistry; Metallurgy | 2 | Active |
| US9925248B2 | Methods and compositions for RNA-guided treatment of HIV infection | Chemistry; Metallurgy | 2 | Active |
| US11273209B2 | Methods and compositions for RNA-guided treatment of HIV infection | Chemistry; Metallurgy | 1 | Active |
| US11291710B2 | Methods and compositions for RNA-guided treatment of HIV infection | Chemistry; Metallurgy | 1 | Active |
| US7612039B2 | Method of cell growth inhibition with agnoprotein | Emerging Cross-Sectional Technologies | 1 | Expired |
| US11236389B2 | BAG3 as a target for therapy of heart failure | Physics | 0 | Active |
| US12251429B2 | Methods and compositions for RNA-guided treatment of HIV infection | Chemistry; Metallurgy | 0 | Active |
| US11542555B2 | BAG3 as a target for therapy of heart failure | Physics | 0 | Active |
| US10161925B2 | Detection of HIV-1-associated neurocognitive disorders | Physics | 0 | Active |
| US11285193B2 | Methods and compositions for RNA-guided treatment of HIV infection | Chemistry; Metallurgy | 0 | Active |
| US12122997B2 | Excision of retroviral nucleic acid sequences | Chemistry; Metallurgy | 0 | Active |
| US10690668B2 | Method for detecting polyomavirus reactivation | Physics | 0 | Active |
| US11298410B2 | Methods and compositions for RNA-guided treatment of HIV infection | Chemistry; Metallurgy | 0 | Active |
| US10279014B2 | Gene editing methods and compositions for eliminating risk of JC virus activation and PML (progressive multifocal leukoencephalopathy) during immunosuppressive therapy | Emerging Cross-Sectional Technologies | 0 | Active |
| US11298411B2 | Methods and compositions for RNA-guided treatment of HIV infection | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.